In this report we propose a model whereby after the herpes simplex virus capsid docks at the nuclear pore, the tegument protein attached to the capsid must be cleaved by a serine or a cysteine protease in order for the DNA to be released into the nucleus. TPCK prevented the release of HSV-1 DNA into the nucleus when added to medium one hour after infection with tsB7at 39.5C followed by shift down to permissive temperature. The ts lesion maps in U L 36 gene. At the nonpermissive temperature the capsids accumulate at the nuclear pore but the DNA is not released into the nucleus.
Introduction
In this report we present supporting evidence for a model for the release of herpes simplex virus 1 (HSV-1) DNA from the capsid into the nucleus of infected cells. Briefly, following the attachment of the capsid to the nuclear pore, VP1-2, the largest tegument protein, undergoes a proteolytic cleavage that cleaves a 55 kDa N-terminal fragment. This proteolytic cleavage is essential for the subsequent conformational changes in the capsid that allow the release of the HSV-1 DNA into the nucleus. Relevant to the presentation of the data supporting the model are the following:
HSV-1 initiates infection by attachment to the cell membrane via the interaction between viral glycoproteins gB and gC with heparan sulfate (39, 43) . The initial attachment is followed by the fusion of the viral envelope with the plasma membrane, a process initiated by the interaction of glycoprotein D (gD) with a specific receptor and mediated by gB, gH and gL (11, 24, 35) . The capsid with associated tegument proteins is released into the cytosol and transported via dynein and microtubule-directed transport towards the nucleus (40). During the transport some tegument proteins, most notably VP16 (2) and virion host shutoff protein 4 mutant tsB7, which carries a temperature-sensitive mutation in the U L 36 gene (1) . When cells are infected with tsB7 mutant at non-permissive temperature capsids are accumulated at the nuclear pores, but DNA fails to be released. DNA is released from tsB7 capsid only upon shift to permissive temperature (1) .
The U L 36 gene is conserved among alpha-, beta-and gamma-herpesvirus subfamilies (36) . VP1-2 plays an essential role in the formation of mature virions, as the deletion of the U L 36 gene leads to the accumulation of DNA-filled, unenveloped capsids in the cytoplasm of infected cells (6) . VP1-2 is tightly associated with capsid (15, 41) , and based on cryoelectron microscopy images it appears that it is localized at the penton structures (44) . VP1-2 interacts with a 140 kDa viral protein that binds the a sequence of HSV-1 DNA (5) and is suggested to interact with VP5 (44) . VP1-2 is the largest protein encoded by the U L 36 gene. It is expressed as a γ (late) gene (28) and based on its sequence, it is predicted to be 366 kDa in mass. However, its apparent molecular mass is about 270 kDa, based on electrophoretic mobility in denaturing gels (41) . The reasons for the difference in predicted and observed size are not clear. Kattenhorn et al. (22) have identified a 450-550 aa N-terminal fragment of VP1-2, as a peptide that appears later during the HSV-1 infection and which was shown to exhibit deubiquitinating activity. 
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Materials and Methods

Cells and viruses. Vero, SK-N-SH and Hep-2 cells were obtained from the American
Type Culture Collection. The telomerase-transformed human embryonic lung fibroblasts (HEL cells) were obtained from T. Shenk (Princeton). Cells were maintained in Dulbecco's modified Eagle's minimal essential medium supplemented with 10% (vol./vol.) newborn calf serum (Vero, Hep-2) or 10% fetal bovine serum (SK-N-SH, HEL). HSV-1(F) is the prototype HSV-1 strain used in our laboratory (10) . Isolation and characterization of HSV-1 (HFEM) tsB7 was described elsewhere (1) .
Virion purification. HSV-1(F) and tsB7 virions were purified as previously described (41) . Briefly, cells grown in roller bottles to 100% confluency were infected and scraped into the medium when 100% cpe was reached. Cells were collected by centrifugation at 2000 rpm for 5 min and resuspended in 1 mM sodium-phosphate buffer, pH 7.4. Cell membranes were disrupted in Dounce homogenizer with tight pestle, medium supplemented with 0.2 M sucrose and nuclei pelleted by centrifugation at 3000 rpm for 5 min. Viral particles from cell lysates and cell medium were collected by ultracentrifugation at 20000 rpm for 2 h in SW28 rotor. Viral particles were resuspended in 1 mM sodium-phosphate buffer (pH 7.4), layered on dextran-10 gradient (1.04 to 1.09 g/cm 3 ) and centrifuged for 2 h at 20000 rpm in SW41 rotor. Light-scattering band 6 DNA. The fragment was ligated into pGEX4T-1 EcoRI restriction site. The construct was then designated as U L 36 (109-333aa)-pGEX4T-1. Codons 3040 to 3165 of U L 36 was PCR amplified from HSV-1 F DNA by using primers EC-U L 36-9118F (5' GAA TTC TCG CTG CTT CAG ACC CTG TAT G 3') and E-C U L 36-B (5' GAA TTC AAT AAT CGA GCG CGT CTA GC 3').
The fragment was then ligated into pGEX4T-1 EcoRI restriction site. The construct was then named U L 36 (3040-3065aa)-pGEX4T-1. Both U L 36-GST constructs were then transformed into BL21 cells, and U L 36-GST fusion proteins were purified as described (12 Generation of recombinant baculoviruses. Recombinant baculoviruses carrying HSV-1 U L 6 or U L 38 genes fused at the C-terminus to GFP were generated using PharMingen
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7 baculovirus expression system as previously described (18, 29 Approximately 100 µg of each sample was electrophoretically separated on SDS-PAGE and electrically transferred onto nitrocellulose membrane. Membrane was blocked with 5% nonfat dry milk in PBS supplemented with 0.05% (vol/vol) Tween-20 (PBT) and reacted with primary antibody diluted in PBT overnight at 4ºC. Anti-ICP4 and anti-US3 antibodies were used at a 1:1000 dilution, anti-actin antibody was diluted according to manufacturer's instruction (1:500) and anti-VP1-2 N antibody was diluted 1:20000. After several rinses with PBT, the membranes were exposed to goat anti-mouse or anti-rabbit alkaline phosphatase (AP)-conjugated secondary antibody diluted in PBT according to manufacturers instructions, for 1 h at room temperature.. Immunofluorescence. U2OS cells were grown on 4-well slides (ERIE Scientific, Portsmouth, NH) and transduced with baculoviruses carrying U L 6-GFP or U L 38-GFP constructs.
16 h later cells were rinsed with PBS, fixed in methanol at -80ºC for 2 h and air dried. The samples were mounted in Vectashield mounting medium for fluorescence (Vector Laboratories, Inc., Burlingame, CA) and cellular localization of GFP constructs determined by fluorescence microscopy using Zeiss (Thornwood, NY) confocal microscope.
Results
TPCK prevents the expression of ICP4 protein. Experiments were done to test
whether proteolytic cleavage is required for the release of HSV-1 genomic DNA into the nucleus consistent with the hypothesis that the event blocked by TPCK occurs at or before the release of viral DNA from the capsids.
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Another issue addressed in this experiment was whether TPCK prevents the entry of viral particles into the cells, as that would also render viral DNA nuclease resistant. As a part of nuclease assay, attached, unpenetrated virions were removed by proteinase-K treatment prior to harvesting of the cells as described previously (32) . Very little viral DNA was detected in control group, kept at 10ºC throughout the entire experiment, which allows attachment of viral particles to the cell membrane, but does not allow viral entry, indicating that the removal of attached, unpenetrated virions was successful (compare lanes 4 and 8). Therefore, viral DNA detected in infected cells treated with TPCK corresponded to viral DNA enclosed in the capsid that were
protected from protease K digestion and hence inside the infected cell. This conclusions revisited in additional experiments described below.
Nuclear import is not impaired in cells treated with TPCK. Since previous results
showed that TPCK prevents the release of viral DNA into the nucleus, and the release of viral DNA depends on nuclear import machinery (33) , experiments were carried out to show whether the effect of TPCK on the release of viral DNA is a consequence of a more general inhibitory effect towards nuclear import. For that purpose, U2OS cells were transduced with baculoviruses carrying HSV-1 U L 6 or U L 38 gene fused C-terminally to GFP (U L 6-GFP and U L 38-GFP, respectively), as described in material and methods. U L 6 and U L 38 are proteins known to localize in the nucleus (3, 34) . To evaluate the effect of TPCK on nuclear import of U L 6-GFP and U L 38-GFP, cells were treated with TPCK either one hour prior (-1 h column) or one hour after (+1 h column) the exposure to baculoviruses. Cellular localization of U L 6-GFP and U L 38-GFP was determined 16 h later by fluorescent microscopy. Results in figure 3A show that in cells exposed to TPCK 1 h after the transduction with baculoviruses U L 6-GFP and U L 38-GFP constructs are expressed, and proteins localized in the nucleus of transduced, TPCK-treated cells, indicating that TPCK does not impair the nuclear import machinery. To eliminate the possibility that protein accumulated in the nucleus was expressed prior to the exposure to TPCK, a control experiment was performed in which U2OS cells were transduced with described baculoviruses, and the expression of constructs evaluated 5 or 16 h later. Results in figure 3B show that constructs were not expressed 5 h following the transduction, which is a time period shown to be more than sufficient for TPCK to inhibit the release of viral DNA into the nucleus. Interestingly,
A C C E P T E D
when cells are exposed to TPCK 1 h prior to transduction with baculoviruses, no GFP fluorescence could be detected. terminus of the protein, the sum of the two polypeptides detected with our antibodies is much smaller than the intact VP1-2 protein and suggest that the protein is cleaved into several polypeptides.
To verify that the 55 kDa protein reactive with the VP1-2 N antibody was indeed derived from VP1-2 protein, replicate roller bottle cultures of Vero cells were mock infected or exposed to 50 PFU of purified HSV-1(F) virions per cell for 4 h. The cells were harvested and lysed in 6 ml of lysis buffer containing 150mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.2% SDS, 5mM DTT, 2mM EDTA, 1% Triton X-100, 1% sarkosyl, 10mM NaF, 0.1mM sodium vanadate, fresh protease inhibitor cocktail We do not know, presently, which protease is responsible for the cleavage of VP1-2.
Based on the specificity of TPCK we can conclude that it is a serine or cysteine protease. Since VP1-2 is cleaved only after it arrives at the nuclear pore, it is likely that the protease is recruited to the capsid once it is attached to the nuclear pore. We cannot completely exclude the possibility that protease responsible for the cleavage of VP1-2 is a viral protease. VP1-2 itself is a cysteine protease, with deubiquitinating activity (22) . It is possible that it has additional specificity, 
